Having trouble reading this email? View the web version here \| Forward this email to a colleague

NUCYNTA® ER (Tapentadol Extended-Release Tablets) receives FDA approval

Janssen Pharmaceuticals, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved NUCYNTA® ER, an oral analgesic taken twice daily, for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time...

Read more >>

More pharmaceutical & life science news:

		Boehringer Ingelheim broadens its breast cancer trial programme for Afatinib Two phase II studies investigating afatinib are now open for recruitment...

		TAK-385 enters into phase 2 clinical trials in Japan TAK-385 used for the treatment of endometriosis and uterine fibroids...

		Pradaxa® (dabigatran etexilate, 150mg bid) shows significant reduction in the risk of stroke In patients with atrial fibrillation taking antiplatelet or other concomitant therapies...

		ELIQUIS® (apixaban) superior to Warfarin for the reduction of stroke or systemic embolism Significantly less major bleeding in patients with Atrial Fibrillation in Phase 3 ARISTOTLE trial...

		Abbott receives FDA approval for ALK gene test Represents significant advance in personalised medicine for patients with non-small-cell lung cancer...

		Novo Nordisk to build new corporate centre Novo Nordisk is investing around 1 billion Danish kroner (134 million euros) in two new office buildings with surrounding green space in Bagsværd, Denmark...

		Linagliptin receives approval in Europe for treatment of type 2 diabetes Linagliptin is the only DPP-4 inhibitor to be approved at one dosage strength for adults with type 2 diabetes in Europe, without any need for dose adjustments...

		Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe Marketing Authorisation from the European Commission for Trajenta® (linagliptin)...

		Bristol-Myers Squibb and Pfizer announce data presentations New data presentations from largest Phase 3 Clinical Trial Program for Stroke Prevention in Atrial Fibrillation...

		Amgen announces PDUFA date for XGEVA® supplemental Biologics License Application The FDA will target a PDUFA action date of April 26, 2012 for the sBLA...

Events, conferences & exhibitions:

HUPO 2011
4 - 7 September 2011, Geneva, Switzerland

RNAi & miRNA Europe
8 - 9 September 2011, Munich, Germany

qPCR Europe
8 - 9 September 2011, Munich, Germany

Pharma eMarketing Congress 2011
13 - 14 September 2011, Lisbon, Portugal

MipTec 2011
20 - 22 September 2011, Basel, Switzerland

ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development
20 - 22 September 2011, Dublin, Ireland

Pharma Outsourcing and Procurement Summit 2011
26 - 27 September 2011, Berlin, Germany

10th Annual ELNS & Advanced Laboratory Solutions Forum
26 - 28 September 2011, Barcelona, Spain

The Drug Development Process – From Discovery to Commercialization
28 - 30 September 2011, Dublin, Ireland

7th Annual Achieving Quality & Process Exellence in the Pharmaceutical Industry
5 - 6 October 2011, Barcelona, Spain

BioProduction 2011
19 - 20 October 2011, Berlin, Germany

The New Health is data driven. Biopharma is swimming in oceans of data, and it’s still growing exponentially. Quintiles is introducing a singular way to aggregate, harmonize and gain insights from your data. Quintiles Infosario™ is a new platform that allows you to view data from multiple sources—sites, labs, ECG, finance, HR and more—all in one place. So you can make better decisions, faster.

Learn how Quintiles can help you move from information to insights—and from insights to outcomes. Watch From Information to Insight at quintiles.com/newhealth

Company directory

Companies featured in our directory include:

- Almac
- BD Diagnostics
- bioMérieux
- BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- Cellular Dynamics International, Inc.
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- Comark Instruments
- DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Add your company >>

Join European Pharmaceutical Review on LinkedIn

Follow European Pharmaceutical Review on Twitter

Like European Pharmaceutical Review on Facebook